Motilides and motilactides: Design and development of motilin receptor agonists as a new class of gastrointestinal prokinetic drugs

Drugs of the Future

Volumn 23, Issue 8, 1998, Pages 861-872

  Faghih, Ramin ^a   Nellans, Hugh N ^a   Plattner, Jacob J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8,9 ANHYDRO N ETHYLNORERYTHROMYCIN A 6,9 HEMIACETAL; 8,9 ANHYDRO N ISOPROPYLNORERYTHROMYCIN A 6,9 HEMIACETAL; A 173508; A 182061; A 81648; ALEMCINAL; ERYTHROMYCIN DERIVATIVE; MITEMCINAL; MOTILIN; PROKINETIC AGENT; UNCLASSIFIED DRUG;

DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; GASTROINTESTINAL MOTILITY; HUMAN; NONHUMAN; REVIEW;

EID: 0031764719     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.08.665573     Document Type: Review

References (86)

1. Tonini, M. Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacol Res 1996, 33: 217-26.
2. Lartey, P.A., Nellans, H.N., Tanaka, S.K. New developments in macrolides: Structures and antibacterial and prokinetic activities. Adv Pharmacol 1994, 28: 307-43.
3. Brown, J.C., Johnson, C.P., Magee, D.F. Effect of duodenal alkalinization on gastric motility. Gastroenterology 1966, 50: 333-9.
4. Brown, J.C., Mutt, V., Dryburgh, J. The further purification of motilin a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol Pharmacol 1971, 49: 399-405.
5. Brown, J.C., Cook, M.A., Dryburgh, J.R. Motilin, a gastric motor activity-stimulating polypeptide: Final purification, amino acid composition and C-terminal residues. Gastroenterology 1972, 62: 401-4.
6. Brown, J.C., Cook, M.A., Dryburgh, J.R. Motilin, a gastric motor activity-stimulating polypeptide: The complete amino acid sequence. Can J Biochem 1973, 51: 533-7.
7. Poitras, P., Reeve, J., Hunkapiller, M.W. et al. Purification and characterization of canine intestinal motilin. Regul Pept 1983, 5: 197-208.
8. Banfield, D.K., MacGillivray, R.T., Brown, J.C. et al. The isolation and characterization of rabbit motilin precursor CDNA. Biochem Biophys Acta 1992, 1131: 341-4.
9. De Clercq, P., Depoortere, I., Macielag, M. et al. Isolation, sequence and bioactivity of chicken motilin. Peptide 1996, 17: 201-8.
10. Kobayashi, S., Iwanaga, T., Fujita, T. et al. Do enterochromaffin cells contain motilin? Arch Histol Jpn 1980, 43: 85-98.
11. Kobayashi, S., Uchida, T. Morphological identification of motilin in the gut. In: Motilin. Z. Itoh (Ed.). Academic Press: San Diego 1990, 53-72.
12. O'Donohue, T.L., Beinfeld, M.C., Chey, W.Y. et al. Identification, characterization and distribution of motilin immunoreactivity in the rat central nervous system. Peptides 1981, 2: 467-77.
13. Depoortere, I., Peeters, T.L. Demonstration and characterization of motilin binding sites in the rabbit cerebellum. Am J Physiol 1997, 272: G994-9.
14. Domschke, W., Strunz, U., Mitzmegg, P. et al. Motilin and motilin analogues: Mode of action. Scand J Gastroenterol 1976, 11: 25-8.
15. Strunz, U., Domschke, W., Domschke, S. et al. Potentiation between 13-Nle-motilin and acetylcholine on rabbit pyloric muscle in vitro. Scand J Gastroenterol 1976, 11: 29-33.
16. Strunz, U., Domschke, W., Mitznegg, P. et al. Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat and human alimentary tract in vitro. Gastroenterology 1975, 68: 1485-91.
17. Itoh, Z. Motilin and clinical application. Peptides 1997, 18: 593-608.
18. Itoh, Z., Takeuchi, S., Aizawa, I. et al. Changes in plasma motilin concentrations and gastrointestinal contractile activity in conscious dogs. Dig Dis 1978, 23: 929-35.
19. Konturek, S.J., Dembinski, A., Krol, R. et al. Effect of 13-Nle-motilin on gastric secretion, serum gastric level and mucosal blood flow in dogs. J Physiol 1977, 264: 665-72.
20. Vantrappen, G.R., Peeters, T.L., Janssens, J. The secretory component of the interdigestive motor complex in man. Scand J Gastroenterol 1979, 14: 663-7.
21. Itoh, Z., Nakaya, M., Suzuki, T. et al. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 1984, 247: G688-94.
22. Zara G.P., Thompson, H.H., Pilot, M.A., Ritchie, H.D. Effects of erythromycin on gastrointestinal tract motility. J Antimicrob Chemother 1985, 16: 175-9.
23. Code C.F., Marlett J.A. The interdigestive myo-electric complex of the stomach and small bowel of dogs. J Physiol 1975, 246: 289-309.
24. Tomomasa, T., Kuroume, T., Arai, H., Wakabayashi, K., Itoh, Z. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986, 31: 157-61.
25. Peeters, T.L., Matthijs, G., Depoortere, I. et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989, 257: G469-74.
26. Ludtke, F.E., Muller, H., Golehofen, K. Direct effects of motilin on isolated smooth muscle from various regions of the human stomach. Pflügers Arch 1989, 414: 558-63.
27. Peeters, T.L., Borrnans, V., Vantrappen, G. Comparison of motilin binding to crude homogenates of human and canine gastrointestinal smooth muscle tissue. Regul Pept 1988, 23: 171-82.
28. Janssens, J., Peeters, T.L., Vantrappen, G. et al. Erythromycin improves delayed gastric emptying in diabetic gastroparesis. New Engl J Med 1990, 322: 1028-31.
29. Itoh, Z., Omura, S. Motilide a new family of macrolide compounds mimicking motilin. Dig Dis Sci 1987, 32: 915-20.
30. Nakayoshi, T., Izumi, M., Shinkai, S., Fujita, M. Comparative study on effects of 14-membered and 16-membered macrolides on gastrointestinal motility in anesthetized dog. Drugs Exp Clin Res 1988, 14: 319-25.
31. Pilot, M.A., Qin, X.Y. Macrolides and gastrointestinal motility. J Antimicrob Chemother 1988, 22: 201-6.
32. Leaders, F., Pittinger, C.B., Long, J.P. Some pharmacological properties of selected antibiotics. Antibiot Chemother 1960, 10: 503-7.
33. Benzi, G., Crema, A., Frigo, G.M. Action of some antibiotics on the extra-hepatic biliary tract. II. Erythromycin. Arch Int Pharmacodyn 1967, 169: 6-14.
34. Nakayoshi, T., Izumi, M., Tatsuta, K. Effects of macrolide antibiotics on gastrointestinal motility in fasting and digestive states. Drugs Exp Clin Res 1992, 18: 103-9.
35. Omura, S., Tsuzuki, K., Sunazuka, T. et al. Macrolides with gastrointestinal motor stimulating activity. J Med Chem 1987, 30: 1941-43.
36. Sunazuka, T., Tsuzuki, K., Marui, S. et al. Motildes, macrolides with gastrointestinal motor stimulating activity. I. Chem Pharm Bull 1989, 37: 2701-9.
37. Tsuzuki, K., Sunazuka, T., Marui, S. et al. Motildes, macrolides with gastrointestinal motor stimulating activity. II. Chem Pharm Bull 1989, 37: 2687-700.
38. Kurath, P., Jones, P.H., Egan, R.S., Perun, T.J. Acid degradation of erythromycin A and erythromycin B. Experientia 1971, 27: 362.
39. Lartey, P.A., Nellans, H.N., Faghih, R. et al. Synthesis of 4″-deoxy motilides: Identification of a potent and orally active prokinetic drug candidate. J Med Chem 1995, 38: 1793-8.
40. Faghih, R., Lartey, P.A., Pagano, T. et al. Effect of 12-deoxygenation on the conformation and prokinetic activity of motilides: Design and synthesis of ABT-229 as a potential prokinetic drug. 13th Int Symp Med Chem (dates, Paris) 1994, Abst P145.
41. Lartey, P.A., Faghih, R., Pagano, T., Nellans, H.N., Petersen, A., Plattner, J.J. Stereoselective deoxygenation of erythromycin A at C-12: Effect of structure and conformation on prokinetic activity. J Antibiot 1995, 48: 730-2.
42. Koga, H., Sato, T., Tsuzuki, K. et al. Potent, acid stable and orally active macrolide-type motilin receptor agonist, GM-611 and the derivatives. Bioorg Med Chem Lett 1994, 4: 1347-52.
43. Faghih, R., Lartey, P.A., Freiberg, L. et al. 9-Deoxo-4″-deoxy-6,9-epoxyerythromycins: Potent prokinetic agents. 206th Natl Meet Am Chem Soc (dates, Chicago) 1993, Abst MEDI239.
44. Faghih, R., Burnell-Curty, C., Nellans, H.N. Personal communication.
45. Burnell-Curty, C., Faghih, R., Pagano, T. et al. A novel 13-membered erythromycin analog via DAST-induced ring contraction. J Org Chem 1996, 61: 5153-4.
46. Eeckhout, C., Fioramonti, J., Reling, P. et al. Comparative effects of erythromycin and a new erythromycin derivative, KC-11458 on postprandial gallbladder emptying in dogs. Neurogastroenterol Motil 1994, 6: 161.
47. Gregory, P.C., Peck, M., Eeckhout, C. KC-11458 a novel motilide, increases gastric tone and reduces the gastric relaxation induced by intraduodenal lipid in dogs. Gastroenterology 1997, 112: A739.
48. Kirst, H.A., Greenwood, B., Gidda, J.S. LY-267108: Gastrointestinal prokinetic agent. Drugs Fut 1992, 17: 18-20.
49. Faghih, R., Nellans, H.N., Petersen, A. et al. Synthesis of A-173508 a potent and orally active motilide. 214th Natl Meet Am Chem Soc (dates, Las Vegas) 1997, MEDI205.
50. Faghih, R., Nellans, H.N., Lartey, P.A. et al. Preparation of 9-deoxo-4″-deoxy-6,9-epoxyerythromycin lactams "motilactides" potent and orally active prokinetic agents. Bioorg Med Chem Lett 1998, 8: 805-10.
51. Peeters, T.L., Depoortere, I., Macielag, M.J. et al. The motilin antagonist ANQ-11125 blocks motilide-induced contractions in vitro in the rabbit. Biochem Biophys Res Commmun 1994, 198: 411-6.
52. Takanashi, H., Yogo, K., Ozaki, K. et al. GM-109 a novel selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. J Pharmacol Exp Ther 1995, 273: 624-8.
53. Morgan, K.G., Go, V.L.W., Szurszewski, J.H. Motilin increases the influence of excitatory myenteric plexus neurons on gastric smooth muscle in vitro. In: Gastrointestinal Motility. J. Christensen (Ed.). Raven Press: New York 1980, 129.
54. Tack, J. Motilin and the enteric nervous system in the control of interdigestive and postprandial gastric motility. Acta Gastroenterol Belg 1995, 58: 21-7.
55. Kitazawa, T., Ishii, A., Taniyama, K. The Leu-motilin (KW-5139) evoked release of acetylcholine from enteric neurones in the rabbit duodenum. Br J Pharmacol 1993, 109: 94-9.
56. Parkman, H.P., Pagano, A.P., Vozzelli, M.A., Ryan, J.P. Gastrokinetic effects of erythromycin: Myogenic and neurogenic mechanisms of action in rabbit stomach. Am J Physiol 1995, 269: G418-26.
57. Parkman, H.P., Pagano, A.P., Ryan, J.P. Erythromycin inhibits rabbit pyloric smooth muscle through neuronal motilin receptors. Gastroenterology 1996, 111: 682-90.
58. Poitras, P., Miller, P., Dickner, M. et al. Heterogeneity of motilin receptors in the gastrointestinal tract of the rabbit. Peptides 1996, 17: 701-7.
59. Ohtawa, M., Mizumoto, A., Hayashi, N. et al. Mechanism of gastroprokinetic effect of EM-523 an erythromycin derivative in dogs. Gastroenterology 1993, 104: 1320-7.
60. Carlson, R.G., Hocking, M.P., Sninsky, C.A., Vogel, S.B. Erythromycin acts through a cholinergic pathway to improve canine-delayed gastric emptying following vagatomy and Roux antrectomy. J Surg Res 1991, 50: 494-8.
61. Ramirez, B., Eaker, E.Y., Drane, W.E. et al. Erythromycin enhances gastric emptying in patients with gastroparesis after vagatomy and antrectomy. Dig Dis Sci 1994, 39: 2295-300.
62. Peeters, T.L. Personal communication.
63. Tack, J., Janssens, J., Vantrappen, G. et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992, 103: 72-9.
64. Chaussade, S. Does erythromycin have a therapeutic role in gastroenterology in 1994? Gastroenterol Clin Biol 1994, 18: 917-9.
65. Kao, C.H., Wang, S.J., Pang, D.Y. Effects of oral erythromycin on upper gastrointestinal motility in patients with non-insulin-dependent diabetes mellitus. Nucl Med Commun 1995, 16: 790-3.
66. Itoh, Z., Mizumoto, A., Hayashi, N. et al. Enhancement of contractile activity in man and dog lower esophageal sphincter (LES) by motilin agonist EM-523. Gastroenterology 1991, 100: A90.
67. Tsai, S.C., Kao, C.H., Pan, D.Y. et al. Effect of oral erythromycin on esophageal motility in patients with non-insulin-dependent diabetes mellitus. Kaohsiung J Med Sci 1995, 11: 430-5.
68. Pennathur, A., Tran, A., Cioppi, M. et al. Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease. Am J Surg 1994, 167: 169-73.
69. Chaussade, S., Michopoulos, S., Sogni, P. et al. Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves. Dig Dis Sci 1994, 39: 381-4.
70. Ramirez, B., Richter, J.E. Promotility drugs in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993, 7: 5-20.
71. Pfeiffer, A., Wendl, B., Pehl, C. et al. Effect of erythromycin on gastroesophageal reflux. Gastroenterol Clin Biol 1991, 15: 561-2.
72. Chami, T.N., Schuster, M.M., Crowell, M.D. et al. Effects of low dose erythromycin on gastrointestinal motility and symptoms in chronic intestinal pseudoobstruction. Gastroenterology 1991, 100: A41.
73. Hanyu, N., Aoki, T., Itoh, Z. et al. Effect of an erythromycin derivative EM-523 on gastric motility in postoperative patients. Gastroenterology 1991, 100: A447.
74. Dull, J.S., Raufinan, J.P., Zakai, D. et al. Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis. Am J Med 1990, 80: 528-30.
75. Fiorucci, S., Distrutti, E., Bassotti, G. et al. Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients. Scand J Gastroenterol 1994, 29: 807-13.
76. Catnach, S.M., Fairclough, P.D. Erythromycin and the gut. Gut 1992, 33: 397-401.
77. Fiorucci, S., Bosso, R., Morelli, A. Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways. Dig Dis Sci 1992, 37: 1678-84.
78. Stem, M.A., Wolf, D.C. Erythromycin as a prokinetic agent: A prospective randomized controlled study of efficacy in nasoenteric tube placement. Am J Gastroenterol 1994, 89: 2011-3.
79. Di Lorenzo, C., Flores, A.F., Ordein, J.J., Martin, S., Hyman, P.E. Effects of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms. Gastroenterology 1991, 100: A437.
80. Chaussade, S., Sogni, P., Couturier, D., Guerre, J. Intravenous erythromycin and gastric emptying. Gastrointest Endosc 1992, 38: 733.
81. Morrison, P.J., Kroodsma, J.M., Koning, R. et al. The safety and pharmacodynamics of a single dose of a new prokinetic macrolide ABT-229 in healthy adult subjects. Gastroenterology 1996, 110: A719.
82. Maes, B.D., Geypens, B., Luypaerts, A. et al. ABT-229 a new motilin agonist increases gastric emptying of solids in man. Gastroenterology 1996, 110: A711.
83. 13C-Octanoic acid breath test to measure gastric emptying rate of solids. Dig Dis Sci 1994, 39: 104-63.
84. Verhagen, M.A.M.T., Samson, M., Kroodsma, J.M. et al. The new motilin agonist ABT-229 strongly stimulates postprandial antral motility in healthy volunteers. Gastroenterology 1996, 110: A776.
85. Verlinden, M., Craft, C., Olson, C. et al. A-81229 a new macrolide agent dose-dependently accelerates solid gastric emptying in healthy volunteers. Gastroenterology 1997, 112: A846.
86. Nakamura T., Ishii, M., Aral, Y. et al. Effect of intravenous administration of EM-523 on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: A pilot study. Clin Ther 1994, 16: 989-99.